Key result
Solanum betaceum extract reduces atorvastatin-induced muscle enzyme elevation and oxidative stress markers in preclinical models.
Why the study?
Does the phenolic-rich fraction of Solanum betaceum mitigate atorvastatin-induced myotoxicity in female Wistar rats?
Does the phenolic-rich fraction of Solanum betaceum mitigate atorvastatin-induced myotoxicity in female Wistar rats?
Answers are grounded in this paper and cite their sources.
The phenolic-rich fraction of Solanum betaceum mitigates atorvastatin-induced myotoxicity in a rat model, suggesting potential as an adjunct therapy to prevent statin-induced muscle damage.
Background Atorvastatin, a widely prescribed cholesterol-lowering medication, has been linked to statin-induced myotoxicity, a condition marked by elevated muscle enzymes and oxidative stress. While statins are essential for managing hypercholesterolemia and preventing cardiovascular diseases, their myotoxic side effects limit broader clinical use. This study investigated the myo-protective effects of the phenolic-rich fraction of Solanum betaceum (PRFSB) in mitigating atorvastatin-induced muscle damage in female Wistar rats. Methods Thirty female Wistar rats were divided into five groups: (1) a true control group receiving distilled water, (2) an atorvastatin-only group, and three treatment groups receiving PRFSB at varying doses (100, 200, and 400 mg/kg) alongside atorvastatin. Muscle enzymes (creatine kinase and lactate dehydrogenase), oxidative stress markers (catalase, superoxide dismutase, and malondialdehyde), and histopathological changes were assessed. Results Atorvastatin significantly elevated serum CK, LDH and oxidative stress markers, while PRFSB administration, particularly at 400 mg/kg, significantly reduced these elevations (p < 0.05). PRFSB restored muscle enzyme levels, normalized antioxidant defenses and reduced lipid peroxidation. Histological analysis revealed that PRFSB-treated groups exhibited preserved muscle architecture with minimal inflammation. Conclusion PRFSB effectively alleviated atorvastatin-induced myotoxicity by reducing oxidative stress, restoring muscle biomarkers and protecting tissue integrity. These findings suggest that PRFSB holds promise as an adjunct therapy to mitigate statin-induced muscle toxicity, warranting further exploration in clinical settings.
No takes yet. Share an insight, caveat, or question.
Mpumbya et al. (2025) studied Atorvastatin-induced myotoxicity (n=30). Phenolic-rich fraction of Solanum betaceum (PRFSB) vs. Atorvastatin-only and distilled water was evaluated on Muscle enzymes, oxidative stress markers, and histopathological changes (p=< 0.05). The phenolic-rich fraction of Solanum betaceum, particularly at /kg, reduced atorvastatin-induced elevations in muscle enzymes and oxidative stress markers.
Synapse has enriched 10 related papers. Consider them for comparative context: